Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Sarah Bock
Goodwin Advises Alesta Therapeutics in Acquisition by BioMarin for up to $490 Million
The Life Sciences M&A team advised Alesta Therapeutics on their definitive agreement to be acquired by BioMarin, a global rare disease biotechnology company. Under the terms of the agreement, BioMarin will acquire Alesta, and Alesta shareholders will receive an upfront payment of $275 million plus up to $215 million in subsequent payments upon achievement of certain development and regulatory milestones.
Goodwin Advises Kelonia Therapeutics in Acquisition by Lilly for $7 Billion, Largest In-Vivo CAR-T Deal to Date
The Life Sciences team advised Kelonia Therapeutics, Inc. (“Kelonia”) on a definitive agreement for Eli Lilly and Company to acquire Kelonia. Kelonia has developed a proprietary in vivo gene placement system (iGPS0) that uses specially engineered lentiviral-based particles designed to efficiently and selectively enter T-cells inside the body, allowing the patient’s own body to generate chimeric antigen receptor T-cell (CAR-T) therapies that can treat underlying disease.
Goodwin Advises Tubulis on Acquisition by Gilead for $3.15 Billion Upfront and Up to $1.85 Billion in Milestones
The Life Science team advised Tubulis GmbH on entering into a definitive agreement to be acquired by Gilead Sciences, Inc. (Nasdaq: GILD). The acquisition significantly expands Gilead’s ADC capabilities by adding next-generation assets and platforms designed to more selectively deliver diverse payloads to tumors and maximize patient benefit.
Goodwin Advises Collegium on Acquisition of AZSTARYS® From Corium Therapeutics for $650 Million Upfront and Up To $135 Million in Milestones
The Life Sciences team advised Collegium Pharmaceutical, Inc. ("Collegium") on a definitive agreement pursuant to which Collegium will acquire AZSTARYS from Corium Therapeutics Holdings, LLC ("Corium Therapeutics") for $650 million in cash with the potential for additional milestone payments up to $135 million depending on future commercial and regulatory milestones.
Goodwin Advises Orna Therapeutics in Acquisition by Eli Lilly for Up to $2.4 Billion
The Life Sciences team advised Orna Therapeutics (“Orna”) on entering into a definitive agreement with Eli Lilly & Company (“Eli Lilly”) in which Eli Lilly will acquire Orna for up to $2.4 billion in cash, inclusive of an upfront payment and subsequent payments upon achievement of certain clinical development milestones.
Iran's Hidden Hand in Middle Eastern Networks
Written by: Stav Shulman, Matan Mimran, Sarah Bock, Mark Lechtik < div class="block-paragraph_advanced"> Executive Summary UNC1860 is a persistent and opportunistic Iranian state-sponsored threat actor that is likely affiliated with Iran's Ministry of Intelligence and Security (MOIS).
Uncovering an Iranian Counterintelligence Operation
Written by: Ofir Rozmann, Asli Koksal, Sarah Bock Today Mandiant is releasing details of a suspected Iran-nexus counterintelligence operation aimed at collecting data on Iranians and domestic threats who may be collaborating with intelligence and security agencies abroad, particularly in Israel. The data collected by this campaign may support the Iranian intelligence apparatus in pinpointing individuals who are interested in collaborating with Iran's perceived adversarial countries.
Uncharmed: Untangling Iran's APT42 Operations
34 minutes ago google cloudblog Written by: Ofir Rozmann, Asli Koksal, Adrian Hernandez, Sarah Bock, Jonathan Leathery APT42, an Iranian state-sponsored cyber espionage actor, is using enhanced social engineering schemes to gain access to victim networks, including cloud environments. The actor is targeting Western and Middle Eastern NGOs, media organizations, academia, legal services and activists.
Deadline Approaching for Reporting 2021 ISO Exercises and ESPP Transfers | JD Supra
Section 6039 of the Internal Revenue Code requires corporations to provide information statements to employees (including former employees) and information filings to the IRS regarding exercises of incentive stock options (“ISOs”) by employees and former employees.
Deadline Approaching For Reporting 2020 ISO Exercises And ESPP Transfers | JD Supra
Section 6039 of the Internal Revenue Code requires corporations to provide information statements to employees (including former employees) and information filings to the IRS regarding exercises of incentive stock options (“ISOs”) by employees and former employees.
Deadline Approaching for Reporting 2019 ISO Exercises and ESPP Transfers | JD Supra
Updated: May 25, 2018: JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.
Deadline Approaching for Reporting 2018 ISO Exercises and ESPP Transfers | JD Supra
Updated: May 25, 2018: JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.
Rule 701 Update – Increased Threshold for Heightened Disclosure Requirements - July 2018 | JD Supra
JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services").
New Adventures Daily
Sarah Bock takes the lead on her family’s farm and in their business ventures How many restaurant managers know the history behind their hamburger? Chances are not many. Sarah Bock, owner and manager of Sundaes restaurant in Stockton, Mo., can tell her customers exactly where the beef is raised, what it was fed, even the color and age of each animal that is processed for her restaurant. All of the beef served at Sundaes is raised by Sarah and her husband Justin on their farm south of Stockton.
Rule 701 Update – Increased Threshold for Heightened Disclosure Requirements | JD Supra
JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations. This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services").
Rule 701 Refresher and Updates
The Securities Act requires that any offer or sale of securities (including stock options, restricted stock units (RSUs) and other equity compensation awards) be registered with the SEC unless an exemption from registration applies. Rule 701 of the Securities Act (Rule 701) is the federal securities exemption most frequently relied upon by private companies to grant or sell compensatory equity awards to their employees and other service providers.
Deadline Approaching for Reporting 2017 ISO Exercises and ESPP Transfers
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Already signed up? Log in here By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
2017 Tax Law's Impact on Compensation and Benefits
Under current law, Section 162(m) of the Internal Revenue Code of 1986 (Code) limits to $1 million the tax deduction that public companies may take for compensation paid to any “covered employee.” The Code Section 162(m) deduction limit generally applies to the compensation paid to any employee of a public company who, as of the close of the fiscal year, is the company’s principal executive officer (i.e., CEO) or one of the company’s three most highly compensated executive officers other than...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Sarah
Contact Sarah, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack